Augmentation of clozapine with valproic acid for clozapine-induced obsessive-compulsive symptoms [3]

Pharmacopsychiatry

Volumn 40, Issue 5, 2007, Pages 202-203

  Zink, M ^a   Englisch, S ^a   Knopf, U ^b   Kuwilsky, A ^a   Dressing, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Psychiatric Center Nordbaden   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPENTIXOL; VALPROIC ACID;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; HUMAN; LETTER; MALE; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PHYSICAL EXAMINATION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCORING SYSTEM; STEREOTYPY;

ADULT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG THERAPY, COMBINATION; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; VALPROIC ACID;

EID: 35148836182     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985885     Document Type: Letter

References (15)

1. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006; 11: 622-632
2. Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci 2005; 30: 187-193
3. Citrome L. Schizophrenia and valproate. Psychopharmacol Bull 2003; 37 (Suppl 2): 74-88
4. Cora-Locatelli G, Greenberg BD, Martin JD, Murphy DL. Valproate monotherapy in an SRI-intolerant OCD patient. J Clin Psychiatry 1998; 59: 82
5. Deltito JA. Valproate pretreatment for the difficult-to-treat patient with OCD. J Clin Psychiatry 1994; 55: 500
6. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Progr Neuro-Psychopharmacol Biol Psychiatry 2003; 27: 333-346
7. Moore DP. Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review. J Clin Psychiatry 1996; 57: 407-414
8. Pasquini M, Garavini A, Biondi M. Nicotine augmentation for refractory obsessive-compulsive disorder. A case report. Progr Neuro-Psychopharmacol Biol Psychiatry 2005; 29: 157-159
9. Poyurovsky M, Koran LM. Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. J Psychiatric Res 2005; 39: 399-408
10. Reznik I, Yavin I, Stryjer R, Spivak B, Gonen N, Strous R et al. Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study. Pharmacopsychiatry 2004; 37: 52-56
11. Sevincok L, Akoglu A, Kokcu F. Suicidality in schizophrenic patients with and without obsessive-compulsive disorder. Schizophrenia Res 2007; 90: 198-202
12. Sievers M, Sato T, Moller HJ, Bottlender R. Obsessive-compulsive disorder (OCD) with psychotic symptoms and response to treatment with SSRI. Pharmacopsychiatry 2005; 38: 104-105
13. Zink M, Dressing H. Augmentation of clozapine with atypical antipsychotic substances. Curr Psychiatry Rev 2005; 1: 165-172
14. Zink M, Knopf U, Kuwilsky A. Management of clozapine-induced obsessive compulsive symptoms in a man with schizophrenia. Austr NZ J Psychiatry 2006; 41: 293-294
15. Zink M, Knopf U, Mase E, Kuwilsky A, Deuschle M. Duloxetine treatment of major depressive episodes in the course of psychotic diseases. Pharmacopsychiatry 2006; 39: 109-111